id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-6580-4612,FDA,FDA-2017-D-6580,Memorandum from American Institute of Homeopathy,Other,Memorandum,2018-05-15T04:00:00Z,2018,5,2018-05-15T04:00:00Z,,2018-05-15T14:24:38Z,,0,0,090000648326985e
FDA-2017-D-6580-3476,FDA,FDA-2017-D-6580,Drug Products Labeled as Homeopathic; Draft Guidance for Staff and Industry; Availability; Extension of Comment Period,Notice,Extension of Comment Period,2018-03-21T04:00:00Z,2018,3,2018-03-21T04:00:00Z,2018-05-22T03:59:59Z,2019-02-02T02:03:50Z,2018-05659,0,0,0900006483035dd8
FDA-2017-D-6580-2278,FDA,FDA-2017-D-6580,Request for Extension from Alliance for Natural Health - USA,Other,Request for Extension,2018-03-13T04:00:00Z,2018,3,2018-03-13T04:00:00Z,,2018-03-13T16:32:45Z,,0,0,0900006482fbe2cc
FDA-2017-D-6580-2166,FDA,FDA-2017-D-6580,Request for Extension from Consumer Healthcare Products Association (CHPA),Other,Request for Extension,2018-02-26T05:00:00Z,2018,2,2018-02-26T05:00:00Z,,2018-02-26T21:29:40Z,,0,0,0900006482f64e2e
FDA-2017-D-6580-2137,FDA,FDA-2017-D-6580,"Request to Extend the Comment Period from American Association of Homeopathic Pharmacists AAHP (Alvin J. Lorman, Counsel)",Other,Request for Extension,2018-02-23T05:00:00Z,2018,2,2018-02-23T05:00:00Z,,2018-02-23T20:57:03Z,,0,0,0900006482f59d55